SC, I know you like out of favor bottom plays, so here's one that looks interesting, Celldex (CLDX). They had a Phase 3 clinical failure which dropped the stock from the 30s down to the current 4.50, but the company has $250 mil in cash and an interesting pipeline (links below). The chart also caught my attention, having formed a bullish ascending triangle over the past 3 months, in the aftermath of the big drop. Interesting looking bottom play -
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.